Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

NCT06832514 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Meningococcal Meningitis, Serogroup B
Transgender Persons
Sex Differences in Immune Response
Vaccination

Interventions

BIOLOGICAL: Serogroup B meningococal vaccine

Sponsor

University Ghent

Collaborators

[object Object]
[object Object]